BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.66: the stock has moved about 34% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) trades at $69.75. BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) is a non-diversified fund focused on long-term capital growth through investments in health sciences and related industries. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for SHSKX: SHSKX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) Financial Services Profile
BlackRock Health Sciences Opportunities Portfolio Class K is a specialized fund focusing on equity securities within the health sciences sector, including healthcare equipment, biotechnology, and pharmaceuticals. With a concentration strategy and global investment scope, SHSKX aims for long-term capital appreciation, operating with a beta of 0.66 and no dividend payouts.
What Is the Investment Thesis for SHSKX?
BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) presents an investment opportunity centered on the long-term growth potential of the health sciences sector. The fund's concentrated investment approach, with at least 80% of its assets in health care equipment, biotechnology, and pharmaceuticals, allows it to capitalize on the sector's innovation and expansion. Key to the investment thesis is the aging global population and increasing demand for healthcare services. The fund's global investment scope offers diversification and access to international markets. However, investors should be aware of the fund's non-diversified nature, which can lead to higher volatility compared to broader market funds. The fund's beta of 0.66 suggests lower volatility than the overall market. The absence of dividend payouts means returns are solely dependent on capital appreciation.
Based on FMP financials and quantitative analysis
SHSKX Key Highlights
Market capitalization of $6.60 billion, indicating a substantial presence in the asset management industry.
- Concentrated investment strategy with at least 80% of total assets allocated to equity securities in the health sciences sector.
- Focus on health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals.
- Global investment scope, including companies located in non-U.S. countries, providing diversification.
- Beta of 0.66, suggesting lower volatility compared to the broader market.
Who Are SHSKX's Competitors?
SHSKX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| FSPHX Fidelity Select Health Care Portfolio | $29.89 | +1.81% | $6.84B | — |
| LMGNX ClearBridge International Growth I | $74.31 | -0.39% | $7.27B | — |
| PRPFX Permanent Portfolio Class I | $77.34 | +0.35% | $7.31B | — |
| RBAIX T. Rowe Price Balanced I Class | $29.86 | +0.30% | $5.27B | — |
| SHISX BlackRock Health Sciences Opportunities Portfolio Service Shares | $64.05 | +0.61% | $6.40B | — |
| BLK BlackRock, Inc. | $1066.45 | +0.64% | $165B | 51 5-pillar |
| BX Blackstone Inc. | $111.64 | -0.09% | $136B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | 0.00% | $74.8B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SHSKX's Key Strengths?
Strong focus on the health sciences sector.
- Managed by BlackRock, a leading global asset manager.
- Potential for high growth due to the expanding healthcare industry.
- Global investment scope provides diversification.
What Are SHSKX's Weaknesses?
Non-diversified fund, which can lead to higher volatility.
- Concentrated investment approach may increase risk.
- Performance is highly dependent on the health sciences sector.
- No dividend payouts, relying solely on capital appreciation.
What Are the Key Risks for SHSKX?
Regulatory changes impacting the healthcare industry, such as drug pricing policies.
- Economic downturns leading to reduced healthcare spending.
- Competition from other health sciences funds and investment vehicles.
- Patent expirations and generic drug competition affecting pharmaceutical companies.
- Market volatility and fluctuations in the health sciences sector.
What Are SHSKX's Competitive Advantages?
- Established brand and reputation of BlackRock, a leading global asset manager.
- Access to BlackRock's extensive research and investment expertise.
- Concentrated investment approach allows for focused expertise in the health sciences sector.
What Does SHSKX Do?
BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) is a non-diversified fund managed by BlackRock, Inc., a leading global investment management firm. The fund is designed to provide long-term capital growth by investing primarily in the equity securities of companies operating within the health sciences and related industries. This includes companies involved in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. The fund's investment strategy involves concentrating its assets, with at least 80% of its total assets allocated to companies in these sectors. This concentrated approach allows the fund to focus on specific areas within the health sciences industry that BlackRock believes have strong growth potential. SHSKX may also invest in companies located in non-U.S. countries, providing it with a global perspective and access to international health sciences markets. The fund's objective is to achieve long-term capital appreciation through strategic investments in the health sciences sector. As of today, March 17, 2026, the fund has a market capitalization of $6.60 billion, reflecting its significant presence in the asset management landscape. The fund does not distribute dividends, focusing instead on reinvesting earnings to fuel further growth. The fund maintains a beta of 0.66, indicating lower volatility compared to the broader market.
What Products and Services Does SHSKX Offer?
- Invests primarily in equity securities of companies in health sciences and related industries.
- Focuses on companies in health care equipment and supplies.
- Targets companies in health care providers and services.
- Allocates investments to companies in biotechnology.
- Includes companies in pharmaceuticals.
- Concentrates investments in health sciences or related industries.
- May invest in companies located in non-U.S. countries.
How Does SHSKX Make Money?
- Generates revenue through capital appreciation of its investments in health sciences companies.
- Focuses on long-term growth of capital by strategically allocating assets to companies with strong growth potential.
- Charges management fees based on a percentage of the fund's assets under management (AUM).
What Industry Does SHSKX Operate In?
BlackRock Health Sciences Opportunities Portfolio Class K operates within the asset management industry, specifically targeting the health sciences sector. The global healthcare market is experiencing significant growth, driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. This growth is expected to continue, creating opportunities for investment in companies within the health care equipment, biotechnology, and pharmaceutical industries. SHSKX competes with other health sciences-focused funds, such as FSPHX, LMGNX, PRPFX, RBAIX, and SHISX, each with its own investment strategy and risk profile. The competitive landscape is characterized by varying degrees of concentration, geographic focus, and investment styles.
Who Are SHSKX's Key Customers?
- Institutional investors seeking exposure to the health sciences sector.
- Individual investors looking for long-term capital growth.
- Retirement plans and other investment vehicles.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
SHSKX Financials
Bull Case vs Bear Case
Bull Case
- Strong focus on the health sciences sector.
- Managed by BlackRock, a leading global asset manager.
- Potential for high growth due to the expanding healthcare industry.
- Global investment scope provides diversification.
Bear Case
- Non-diversified fund, which can lead to higher volatility.
- Concentrated investment approach may increase risk.
- Performance is highly dependent on the health sciences sector.
- No dividend payouts, relying solely on capital appreciation.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
SHSKX Latest News
No recent news available for SHSKX.
SHSKX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for SHSKX.
Price Targets
Wall Street price target analysis for SHSKX.
SHSKX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for SHSKX; grades run from A+ (80-100) to F (below 30).
BlackRock Health Sciences Opportunities Portfolio Class K Financials Stock: Key Questions Answered
What are the main risks for SHSKX?
The main risks for BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) include regulatory changes in the healthcare industry, such as drug pricing policies and healthcare reform initiatives, which can significantly impact the profitability of companies in the portfolio. Economic downturns can lead to reduced healthcare spending, affecting the demand for healthcare services and products.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The information provided is based on available data and may be subject to change.
- Investment decisions should be made based on individual risk tolerance and financial goals.